New Jersey jury hits BD subsidiary Bard with $33m pelvic mesh verdict

New Jersey jury hits BD subsidiary Bard with $33m pelvic mesh verdict

Source: 
Mass Device
snippet: 

Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard was reportedly hit yesterday with a $33 million verdict in a product liability lawsuit brought over its Avaulta and Align pelvic mesh products.